In addition to its role in radiotherapy resistance, FOXM1 contributes to chemotherapy resistance in GBM through its transactivation of Replication Factor C Subunit 5 (RFC5), a DNA repair protein. This evidence concerns the gene RFC5 and glioblastoma.